PET Scan
PET Scan
HYBRID IMAGING
Combination
Nuclear medicine
Radiology
PET/CT
Positron emission tomography
Computed tomography
SPECT/CT
Single photon emission tomography
Computed tomography
PET/MRI
Beta plus decay
Nucleus reach of protons
Proton is transformed to neutron 18F
n g 511 keV
Emission of positron and neutrino
Periodical table shift to the left by one site
18F to18O
Positron is living only few ms
Annihilation of the matter
Interaction of electron and positron e+
Gamma rays 180
2 quanta E – 511 keV e-
Unique energy
Angle180o
511 keV g
PET/CT scanner
Radiopharmaceuticals
18F halftime110 min
18FDG – fluorodeoxyglucose
18FLT – fluorothymidine
Na18F
18F-Estradiol, 18F-methionin, 18F-DOPA, 18F-cholin
68Ga halftime 68 min
DOTA derivates
somatostatine analoga
11C halftime 20 min
11C-acetate, 11C-cholin
13N (9 min), 15O (123 s), 82Rb (78 s)
Imaging technique
Application of radiofarmaka
Oral preparation
1000 ml 2,5% manitol
CT data acquisition
PET data acquisition
7 positions per 3 min
Oral preparation
2,5% mannitol
Postprocessing fusion CT + PET
plasma cell
Increased uptake
Tumorous tissues with increased glycolytic activity
Inflammatory reaction
Physiological uptake
brain
Brown fatty tissue
Stripped muscles
Kidneys
Sallivary glands
staging
Bronchogenic carcinoma
Head and neck tumours
Lymfoma
Melanoblastoma
BRCA
BRCA
Cerebral lymphoma
Hodgkin disease
Therapy strategy
Sarcoma tendinis Achill. Leiomyosarkoma Synovial sarcoma
Restaging
Therapy response effect
Definitive
In the middle between cycles
Oropharyngeal cancer
18 months after
Early after surgery 3 months later
Cervical cancer
myom
myom
Ca
Ca
Before th After th
Grading
the assesment of the biologic activity
More dedifferenciated – higher FDG uptake
Low-grade astrocytoma
Anaplastic oligodendroglioma
Fever of unknown origin
M. Hodgkin
Blastic turnover of the osteomyelofibrosis
Microscopic polyarteritis
18F-fluorothymidine
Bone turnover
fluoroapatite
Osteoblastic activity
Osteoplastic bone metastases
Ca prostate
Ca breast
Ca lungs
Bony tumors
Indications